Shots:
Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Apart from the exposure and capital raise, companies gain more recognition, credibility, and indispensable value assessment
2022 had been a great year when it comes to the IPOs of healthcare companies. Bausch…
